Rezultati
eNauka >
Results >
primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma
| Title: | primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma | Authors  : | Van, Akkooi Alexander CJ; ...; Matkovic, Suzana; ...; (broj, koautora 38) | Issue Date: | 2026 | Publication: | EUROPEAN JOURNAL OF CANCER | ISSN: | 0959-8049 European Journal of Cancer / EJC Search Idenfier |
Type: | Article | Collation: | vol. 245 str. 116951-116951 | DOI: | 10.1016/j.ejca.2026.116951 | WoS-ID: | 001836331600001 | Scopus-ID: | 2-s2.0-105045632111 | URI: | https://enauka.gov.rs/handle/123456789/1049340 | Project: | Pierre Fabre | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21aM21a |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.